| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 increases MLC phosphorylation
and endothelial monolayer permeability
Center for Cardiovascular Sciences, Albany Medical College, Albany, New York 12208
Transforming growth
factor (TGF)-
1 increases endothelial monolayer permeability and
myosin light chain phosphorylation (MLC-P) beginning 1-2 h
posttreatment, suggesting that changes in gene expression may be
required for these responses. The role of extracellular signal-regulated kinase (ERK) 1/2 and p38 mitogen-activated protein kinase (p38 MAPK) was investigated because both kinases have been implicated in regulating gene expression after TGF-1. ERK1/2 phosphorylation increased threefold above the control level, and the
increase was temporally associated with the increase in MLC-P. Inhibition of ERK1/2 phosphorylation with the MAPK kinase inhibitor U-0126 did not prevent the increase in either monolayer permeability or
MLC-P. p38 MAPK phosphorylation increased fourfold above the control
level, but unlike ERK1/2, this increase peaked 30 min and 1 h
post-TGF-1 treatment. Inhibition of p38 MAPK activity with SB-203580
prevented the increases in both monolayer permeability and MLC-P.
Treatment of the monolayers with cycloheximide in conjunction with
TGF-1-inhibited MLC-P, showing a requirement for protein synthesis.
These studies demonstrate that p38 MAPK activation and subsequent
protein synthesis are part of the signal transduction pathway leading
to the TGF-1-induced increases in monolayer permeability and
MLC-P.
transforming growth factor-1; myosin light chain
phosphorylation; endothelial cells; cycloheximide; mitogen-activated
protein kinase
This article has been cited by other articles:
|
|
 |
|
  A. Antonov, C. Snead, B. Gorshkov, G. N. Antonova, A. D. Verin, and J. D. Catravas Heat Shock Protein 90 Inhibitors Protect and Restore Pulmonary Endothelial Barrier Function Am. J. Respir. Cell Mol. Biol., November 1, 2008; 39(5): 551 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. H. Lee, U. S. Kayyali, A. M. Sousa, T. Rajan, R. J. Lechleider, and R. M. Day Transforming Growth Factor-beta1 Effects on Endothelial Monolayer Permeability Involve Focal Adhesion Kinase/Src Am. J. Respir. Cell Mol. Biol., October 1, 2007; 37(4): 485 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Csortos, I. Kolosova, and A. D. Verin Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L843 - L854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Figueiredo, P. M. S. Deccache, L. M. Lopes-Bezerra, and V. Morandi TGF-beta1 induces transendothelial migration of the pathogenic fungus Sporothrix schenckii by a paracellular route involving extracellular matrix proteins Microbiology, September 1, 2007; 153(9): 2910 - 2921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Boon, J. O. Fledderus, O. L. Volger, E. J.A. van Wanrooij, E. Pardali, F. Weesie, J. Kuiper, H. Pannekoek, P. ten Dijke, and A. J.G. Horrevoets KLF2 Suppresses TGF-{beta} Signaling in Endothelium Through Induction of Smad7 and Inhibition of AP-1 Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 532 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Lu, E. O. Harrington, H. Jackson, N. Morin, C. Shannon, and S. Rounds Transforming growth factor-beta1-induced endothelial barrier dysfunction involves Smad2-dependent p38 activation and subsequent RhoA activation J Appl Physiol, August 1, 2006; 101(2): 375 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Sen, S. Khanna, and S. Roy Perceived hyperoxia: Oxygen-induced remodeling of the reoxygenated heart Cardiovasc Res, July 15, 2006; 71(2): 280 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Birukova, K. G. Birukov, B. Gorshkov, F. Liu, J. G. N. Garcia, and A. D. Verin MAP kinases in lung endothelial permeability induced by microtubule disassembly Am J Physiol Lung Cell Mol Physiol, July 1, 2005; 289(1): L75 - L84. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Lebrin, M. Deckers, P. Bertolino, and P. ten Dijke TGF-{beta} receptor function in the endothelium Cardiovasc Res, February 15, 2005; 65(3): 599 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Clements, F. L. Minnear, H. A. Singer, R. S. Keller, and P. A. Vincent RhoA and Rho-kinase dependent and independent signals mediate TGF-{beta}-induced pulmonary endothelial cytoskeletal reorganization and permeability Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L294 - L306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. K. Sheares, T. K. Jeffery, L. Long, X. Yang, and N. W. Morrell Differential effects of TGF-{beta}1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L919 - L927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Masszi, C. Di Ciano, G. Sirokmany, W. T. Arthur, O. D. Rotstein, J. Wang, C. A. G. McCulloch, L. Rosivall, I. Mucsi, and A. Kapus Central role for Rho in TGF-beta 1-induced alpha -smooth muscle actin expression during epithelial-mesenchymal transition Am J Physiol Renal Physiol, May 1, 2003; 284(5): F911 - F924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Rudarakanchana, J. A. Flanagan, H. Chen, P. D. Upton, R. Machado, D. Patel, R. C. Trembath, and N. W. Morrell Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension Hum. Mol. Genet., June 15, 2002; 11(13): 1517 - 1525. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
